Company / Shareholders' Equity
CASTLE BIOSCIENCES INC Shareholders' Equity History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$470.9M
FY2025
5-year range
$391.3M / $470.9M
FY2021-FY2025
Trend
+3.3%
vs FY2024
Sector context
#108 of 160
Health Care
What the data says
At $471M, CASTLE BIOSCIENCES INC's shareholders' equity ranks #108 of 160 in the Health Care sector. Improved from $391M to $471M over the past 2 years.
Based on SEC 10-K filings.
$471M in FY2025 with a 5-year CAGR of +2.5%.
Improved from $391M to $471M over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +5.7%
- 5-Year CAGR
- +2.5%
- 10-Year CAGR
- -
Sector benchmark
#108 of 160 in Health CareTop 68% of 160This company $470.9M Sector average $5.0B
▼
-90.7% below sector average
Key checks
Key Insights
- 5-year CAGR of +2.5%, indicating consistent growth.
- In FY2025, shareholders' equity increased 3.3% year-over-year.
- Ranks #108 out of 160 companies in the Health Care sector.
- Lowest shareholders' equity in the period was in FY2018.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $470.9M | +3.3% |
| FY2024 | $455.8M | +16.5% |
| FY2023 | $391.3M | -2.0% |
| FY2022 | $399.1M | -3.1% |
| FY2021 | $411.7M | -1.0% |
| FY2020 | $415.7M | +388.4% |
| FY2019 | $85.1M | +250.5% |
| FY2018 | -$56.6M | - |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026